BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · IEX Real-Time Price · USD
26.19
+0.26 (1.00%)
At close: Jul 19, 2024, 4:00 PM
26.07
-0.12 (-0.46%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
BridgeBio Pharma Employees
BridgeBio Pharma had 550 employees as of December 31, 2023. The number of employees increased by 158 or 40.31% compared to the previous year.
Employees
550
Change (1Y)
158
Growth (1Y)
40.31%
Revenue / Employee
$397,449
Profits / Employee
-$978,658
Market Cap
4.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 550 | 158 | 40.31% |
Dec 31, 2022 | 392 | -186 | -32.18% |
Dec 31, 2021 | 578 | 193 | 50.13% |
Dec 31, 2020 | 385 | 137 | 55.24% |
Dec 31, 2019 | 248 | 96 | 63.16% |
Dec 31, 2017 | 152 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
PACS Group | 32,433 |
RadNet | 7,872 |
Merit Medical Systems | 6,950 |
Haemonetics | 3,657 |
Doximity | 827 |
Apellis Pharmaceuticals | 702 |
TransMedics Group | 584 |
BBIO News
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO - GlobeNewsWire
- 9 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO - GlobeNewsWire
- 16 days ago - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - BridgeBio Pharma, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - BBIO - Accesswire
- 27 days ago - Levi & Korsinsky Reminds BridgeBio Investors of the Ongoing Investigation into Potential Violations of Securities Laws - BBIO - Accesswire
- 27 days ago - Lost Money on BridgeBio Pharma, Inc.(BBIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - Accesswire
- 4 weeks ago - BridgeBio Pharma, Inc. (BBIO) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire
- 4 weeks ago - BridgeBio Pharma, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - BBIO - Accesswire